Treatment Duration for ESBL Urinary Source Bacteremia

Standard Treatment Duration

The American College of Physicians and other medical societies support 7 days as the optimal treatment duration for gram-negative bacteremia (including ESBL-producers) originating from a urinary source, with multiple randomized controlled trials demonstrating non-inferiority of 7 days compared to 14 days for patient-centered outcomes, including clinical cure, clinical failure, relapse, and all-cause mortality 1

Source control has been adequately addressed, such as removal of obstructions, drainage of collections, or catheter removal, and the patient is hemodynamically stable and has been afebrile for at least 48 hours, with appropriate antimicrobial therapy initiated based on susceptibility testing 2, 3

Treatment duration should be extended to 10-14 days in male patients when prostatitis cannot be clinically excluded, as occult prostatic involvement requires longer therapy, with the European Urology association recommending extended treatment in such cases 3, 4
The Infectious Diseases Society of America recommends extending treatment to 10-14 days in cases of persistent fever beyond 72 hours despite appropriate antimicrobial therapy, inadequate or delayed source control, deep-seated infections, or persistent bacteremia 2, 4

The presence of ESBL production does not necessitate longer treatment duration compared to non-ESBL organisms, with the critical factor being the selection of an appropriate antimicrobial agent, such as a carbapenem, to which the organism is susceptible 1, 2

The European Urology association recommends meropenem 1-2 grams IV every 8 hours for severe infections, and ertapenem 1 gram IV daily for step-down therapy once clinical stability is achieved 2, 4

Patients should be reassessed at 4-7 days of therapy, with repeat blood cultures, imaging, and verification of antimicrobial susceptibility and adequate dosing for renal function as needed 1, 2